BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Platt J, Cox R, Enns GM. Points to consider in the clinical use of NGS panels for mitochondrial disease: an analysis of gene inclusion and consent forms. J Genet Couns 2014;23:594-603. [PMID: 24399097 DOI: 10.1007/s10897-013-9683-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Vos S, van Diest PJ, Ausems MG, van Dijk MR, de Leng WW, Bredenoord AL. Ethical considerations for modern molecular pathology: Ethical considerations for modern molecular pathology. J Pathol 2018;246:405-14. [DOI: 10.1002/path.5157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Malsagova KA, Butkova TV, Kopylov AT, Izotov AA, Potoldykova NV, Enikeev DV, Grigoryan V, Tarasov A, Stepanov AA, Kaysheva AL. Pharmacogenetic Testing: A Tool for Personalized Drug Therapy Optimization. Pharmaceutics 2020;12:E1240. [PMID: 33352764 DOI: 10.3390/pharmaceutics12121240] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mallett A, Patel C, Maier B, McGaughran J, Gabbett M, Takasato M, Cameron A, Trnka P, Alexander SI, Rangan G, Tchan MC, Caruana G, John G, Quinlan C, McCarthy HJ, Hyland V, Hoy WE, Wolvetang E, Taft R, Simons C, Healy H, Little M. A protocol for the identification and validation of novel genetic causes of kidney disease. BMC Nephrol 2015;16:152. [PMID: 26374634 DOI: 10.1186/s12882-015-0148-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
4 Haga SB, Mills R. A review of consent practices and perspectives for pharmacogenetic testing. Pharmacogenomics 2016;17:1595-605. [PMID: 27533720 DOI: 10.2217/pgs-2016-0039] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
5 Martin AR, Williams E, Foulger RE, Leigh S, Daugherty LC, Niblock O, Leong IUS, Smith KR, Gerasimenko O, Haraldsdottir E, Thomas E, Scott RH, Baple E, Tucci A, Brittain H, de Burca A, Ibañez K, Kasperaviciute D, Smedley D, Caulfield M, Rendon A, McDonagh EM. PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels. Nat Genet 2019;51:1560-5. [PMID: 31676867 DOI: 10.1038/s41588-019-0528-2] [Cited by in Crossref: 61] [Cited by in F6Publishing: 47] [Article Influence: 30.5] [Reference Citation Analysis]
6 Bijlsma RM, Bredenoord AL, Gadellaa-Hooijdonk CG, Lolkema MP, Sleijfer S, Voest EE, Ausems MG, Steeghs N. Unsolicited findings of next-generation sequencing for tumor analysis within a Dutch consortium: clinical daily practice reconsidered. Eur J Hum Genet 2016;24:1496-500. [PMID: 27071717 DOI: 10.1038/ejhg.2016.27] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
7 Consugar MB, Navarro-Gomez D, Place EM, Bujakowska KM, Sousa ME, Fonseca-Kelly ZD, Taub DG, Janessian M, Wang DY, Au ED, Sims KB, Sweetser DA, Fulton AB, Liu Q, Wiggs JL, Gai X, Pierce EA. Panel-based genetic diagnostic testing for inherited eye diseases is highly accurate and reproducible, and more sensitive for variant detection, than exome sequencing. Genet Med 2015;17:253-61. [PMID: 25412400 DOI: 10.1038/gim.2014.172] [Cited by in Crossref: 141] [Cited by in F6Publishing: 119] [Article Influence: 17.6] [Reference Citation Analysis]
8 Roche MI, Berg JS. Incidental Findings with Genomic Testing: Implications for Genetic Counseling Practice. Curr Genet Med Rep 2015;3:166-76. [PMID: 26566463 DOI: 10.1007/s40142-015-0075-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 8.1] [Reference Citation Analysis]
9 Tong W, Wang Y, Lu Y, Ye T, Song C, Xu Y, Li M, Ding J, Duan Y, Zhang L, Gu W, Zhao X, Yang XA, Jin D. Whole-exome Sequencing Helps the Diagnosis and Treatment in Children with Neurodevelopmental Delay Accompanied Unexplained Dyspnea. Sci Rep 2018;8:5214. [PMID: 29581464 DOI: 10.1038/s41598-018-23503-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
10 Chambers C, Jansen LA, Dhamija R. Review of Commercially Available Epilepsy Genetic Panels. J Genet Couns 2016;25:213-7. [PMID: 26536886 DOI: 10.1007/s10897-015-9906-9] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
11 Kamps R, Brandão RD, Bosch BJ, Paulussen AD, Xanthoulea S, Blok MJ, Romano A. Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification. Int J Mol Sci 2017;18:E308. [PMID: 28146134 DOI: 10.3390/ijms18020308] [Cited by in Crossref: 193] [Cited by in F6Publishing: 161] [Article Influence: 38.6] [Reference Citation Analysis]
12 Haga SB, Kantor A. Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic Testing. Health Aff (Millwood) 2018;37:717-23. [PMID: 29733708 DOI: 10.1377/hlthaff.2017.1564] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
13 Schilit SL, Schilit Nitenson A. My Identical Twin Sequenced our Genome. J Genet Couns 2017;26:276-8. [PMID: 27853911 DOI: 10.1007/s10897-016-0046-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]